1066.HK - Shandong Weigao Group Medical Polymer Company Limited

HKSE - HKSE Delayed Price. Currency in HKD
5.690
-0.060 (-1.043%)
At close: 4:08PM HKT
Stock chart is not supported by your current browser
Previous Close5.750
Open5.720
Bid0.000 x 0
Ask0.000 x 0
Day's Range5.650 - 5.800
52 Week Range4.500 - 6.530
Volume3,710,193
Avg. Volume3,020,399
Market Cap25.73B
Beta0.20
PE Ratio (TTM)20.48
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.01 (1.73%)
Ex-Dividend Date2017-10-26
1y Target EstN/A
  • Shandong Weigao to Buy Argon in China's Latest U.S. Health Deal
    Bloomberg2 months ago

    Shandong Weigao to Buy Argon in China's Latest U.S. Health Deal

    Shandong Weigao Group Medical Polymer Co. agreed to buy closely held Argon Medical Devices Inc. for $850 million, continuing a string of deals by Chinese companies seeking to gain a foothold in the U.S. ...

  • Reuters2 months ago

    Chinese medical devices maker to buy US-based Argon for $850 mln

    China's Shandong Weigao Group Medical Polymer Co Ltd has agreed to acquire US-based and unlisted Argon Medical Devices Holdings Inc for $850 million, as part of its overseas expansion drive. Weigao Group, mainly engaged in the production and sale of medical devices, orthopaedic and blood purification products, has been seeking opportunities to bolster its product portfolio, the company said in a filing to the Hong Kong Stock Exchange. The company has also been looking to diversify its revenue stream to increase the contribution of sales from overseas markets, and expects "significant growth opportunities" for Argon Medical's products in China.

  • We're sorry this is all we were able to find about this topic.